Back to Ovarian Cancer
NCT05751252
NCT05751252
Who may be able to join
Who might be able to join this trial:
- You weigh at least 51 kg (about 112 lbs)
- Your Body Mass Index (BMI) is between 20 and 25 (a measure of height-to-weight ratio)
- You are a woman diagnosed with Polycystic Ovary Syndrome (PCOS) with specific hormone levels — AMH above 28 pmol/L, LH above 8 IU/mL, and testosterone above 0.39 ng/mL (confirm with trial site)
- You have not used any hormonal treatments or hormonal contraception for at least 2 months
- You are covered by the Social Security system (confirm with trial site for which country/system this applies to)
Who may not be able to join:
- You are currently using any hormonal treatment or hormonal contraception
- You are currently taking Metformin (a medication often used for diabetes or PCOS)
- You are currently pregnant
- You are unable to read or understand the study information/newsletter provided to participants
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Early Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Early Phase 1
Sponsor
University Hospital, Lille
Registry
clinicaltrials_gov
Start date
17 April 2024
Est. completion
9 February 2025
Where this trial is recruiting
🇫🇷 France
Primary endpoints
Serum LH level
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.